Skip to main content

The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.

Parpart-Li S, Bartlett B, Popoli M, Adleff V, Tucker L, Steinberg R, Georgiadis A, Phallen J, Brahmer J, Azad N, Browner I, Laheru D, Velculescu VE, Sausen M, Diaz LA Jr

Publication: Clin Cancer Res (2017) • Vol 23 • Page 2471-2477PMID: 27827317View on PubMed

Purpose

This paper investigated the effects of delayed centrifugation, storage temperature, and collection tube type on levels of cell-free DNA (cfDNA) and mutant allele frequency in plasma. Additionally, cfDNA yield, fragment size, and mutant allele frequency were compared in plasma and serum specimens.

Conclusion

Serum had a much higher number of genome equivalents cfDNA but a much lower mutant allele fraction and a larger fragment distribution. The volume of plasma obtained decreased with increasing room temperature storage, regardless of tube type. The genome equivalents of cfDNA increased and the mutant allele frequency decreased when blood was stored in K2EDTA tubes at room temperature but were stable when blood was stored in BCT. Storage of blood in K2EDTA tubes at 4˚C mitigated most of the effects of delayed processing, but specimens in K2EDTA tubes after three days had a noticeable increase in genomic DNA and a larger percent change in mutant allele fraction than those stored in BCT.

Studies (3)

Purpose

This study compared cfDNA yield, fragment size, and mutant allele frequency in serum and plasma specimens from patients with pancreatic cancer. Blood was collected from 15 pancreatic cancer patients with mutations in KRAS, EGFR, or BRAF into serum, K2EDTA, and BCT tubes. Serum was obtained 15-30 min after blood collection by centrifugation of tubes without anticoagulant at 1000-2000 x g for 10 min followed by recentrifugation of the supernatant in 1 mL aliquots at 18,400 x g for 10 min. Plasma was obtained by centrifugation of blood at 375 x g for 10 min and recentrifugation of the supernatant in 1 mL aliquots at 18,400 x g for 10 min. Plasma and serum aliquots were frozen at -80˚C until use. cfDNA was extracted using the QIAamp Circulating Nucleic Acid Kit and quantified using the Qubit dsDNA HS Assay Kit. Genomic equivalents of wild-type and mutant DNA were determined by droplet digital PCR and fragment size was determined by bioanalyzer.

Summary of Findings

Serum yielded more than 10-fold more genome equivalents of cfDNA than plasma (P<0.001), but the mutant allele fraction in serum was approximately 10% of that observed in plasma (P<0.001). The largest peaks of cfDNA in plasma were 155 bp but there were multiple large fragments ranging from 150 to 2000 bp in serum.

 

  • Biospecimens

    FluidBlood
    FluidSerum
    FluidPlasma
  • Preservation Types

    FrozenStreck/BCT
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNAAutomated electrophoresis/Bioanalyzer
    DNAFluorometry
    DNADigital PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum